1. Home
  2. BENF vs CPHI Comparison

BENF vs CPHI Comparison

Compare BENF & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BENF
  • CPHI
  • Stock Information
  • Founded
  • BENF 2003
  • CPHI N/A
  • Country
  • BENF United States
  • CPHI China
  • Employees
  • BENF N/A
  • CPHI N/A
  • Industry
  • BENF Blank Checks
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BENF Finance
  • CPHI Health Care
  • Exchange
  • BENF Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • BENF 4.6M
  • CPHI 4.0M
  • IPO Year
  • BENF N/A
  • CPHI N/A
  • Fundamental
  • Price
  • BENF $0.44
  • CPHI $0.21
  • Analyst Decision
  • BENF
  • CPHI
  • Analyst Count
  • BENF 0
  • CPHI 0
  • Target Price
  • BENF N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • BENF 199.2K
  • CPHI 701.9K
  • Earning Date
  • BENF 02-13-2025
  • CPHI 03-31-2025
  • Dividend Yield
  • BENF N/A
  • CPHI N/A
  • EPS Growth
  • BENF N/A
  • CPHI N/A
  • EPS
  • BENF N/A
  • CPHI N/A
  • Revenue
  • BENF N/A
  • CPHI $5,544,620.00
  • Revenue This Year
  • BENF N/A
  • CPHI N/A
  • Revenue Next Year
  • BENF $6.38
  • CPHI N/A
  • P/E Ratio
  • BENF N/A
  • CPHI N/A
  • Revenue Growth
  • BENF N/A
  • CPHI N/A
  • 52 Week Low
  • BENF $0.43
  • CPHI $0.13
  • 52 Week High
  • BENF $14.16
  • CPHI $0.50
  • Technical
  • Relative Strength Index (RSI)
  • BENF 27.94
  • CPHI 48.21
  • Support Level
  • BENF $0.43
  • CPHI $0.19
  • Resistance Level
  • BENF $0.50
  • CPHI $0.24
  • Average True Range (ATR)
  • BENF 0.05
  • CPHI 0.02
  • MACD
  • BENF -0.01
  • CPHI 0.00
  • Stochastic Oscillator
  • BENF 2.06
  • CPHI 46.67

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: